Related Experiment Video
Updated: Feb 18, 2026
10:36
Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
20.9K
Probiotics in Newborns and Children
1Division of Pediatric Gastroenterology, University of Florida, PO Box 100296, Gainesville, FL 32610, USA.
Pediatric Clinics of North America
|November 28, 2017
Summary
Probiotics, beneficial live microorganisms, are increasingly studied for their health benefits in children and neonates. This review analyzes current evidence on their use for promoting overall health and preventing diseases in infants.
Area of Science:
- Microbiology
- Pediatrics
- Human Health
Background:
- The human microbiome plays a vital role in development and health.
- Probiotics, live microorganisms conferring health benefits, are extensively researched.
- Their application in infant health is a significant area of study.
Purpose of the Study:
- To review and analyze the scientific evidence on the health benefits of probiotics for children and neonates.
- To evaluate the current understanding of probiotic efficacy in infant populations.
- To differentiate between general health promotion and disease prevention by probiotics.
Main Methods:
- Systematic review of existing scientific literature.
- Analysis of studies investigating probiotic use in pediatric and neonatal populations.
- Evidence-based assessment of reported health outcomes.
Main Results:
- Probiotics demonstrate potential for promoting health in infants.
- Evidence suggests varied efficacy depending on the probiotic strain and health condition.
- Further research is needed to establish definitive roles in disease prevention.
Conclusions:
- Probiotics are a promising area for supporting infant health.
- The specific benefits and applications require more targeted research.
- Careful consideration of evidence is crucial for their use in children and neonates.
More Related Videos
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
324
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
324
01:23Anatomy of the Intestines
88.1K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
88.1K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
257
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
257
01:29Drug Dosing: Infants and Children
341
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
341
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
284
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
284
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
337
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
337